Erkan Cüre

2.2k total citations
102 papers, 1.4k citations indexed

About

Erkan Cüre is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Erkan Cüre has authored 102 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Surgery and 17 papers in Oncology. Recurrent topics in Erkan Cüre's work include Inflammasome and immune disorders (9 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Ocular Diseases and Behçet’s Syndrome (6 papers). Erkan Cüre is often cited by papers focused on Inflammasome and immune disorders (9 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Ocular Diseases and Behçet’s Syndrome (6 papers). Erkan Cüre collaborates with scholars based in Türkiye, United Kingdom and France. Erkan Cüre's co-authors include Medine Cumhur Cüre, Süleyman Yuce, Adem Küçük, Yıldıray Kalkan, Aynur Kırbaş, Levent Tümkaya, Şevket Arslan, Ali Uğur Uslu, Damlanur Sakız and İbrahim Şehitoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, BioMed Research International and Current Pharmaceutical Design.

In The Last Decade

Erkan Cüre

99 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erkan Cüre Türkiye 22 246 242 180 178 176 102 1.4k
Medine Cumhur Cüre Türkiye 22 256 1.0× 225 0.9× 175 1.0× 177 1.0× 204 1.2× 96 1.4k
Alessandra Barassi Italy 23 433 1.8× 208 0.9× 264 1.5× 93 0.5× 108 0.6× 91 1.7k
Caterina Maria Gambino Italy 25 342 1.4× 311 1.3× 163 0.9× 400 2.2× 215 1.2× 82 2.0k
İhsan Ateş Türkiye 21 219 0.9× 113 0.5× 339 1.9× 152 0.9× 84 0.5× 140 1.6k
M. J. Brown United Kingdom 25 244 1.0× 98 0.4× 246 1.4× 122 0.7× 80 0.5× 69 2.3k
Concetta Scazzone Italy 28 243 1.0× 177 0.7× 229 1.3× 298 1.7× 692 3.9× 82 2.1k
Ivan Tancevski Austria 25 434 1.8× 283 1.2× 371 2.1× 140 0.8× 107 0.6× 81 1.9k
Sainan Zhu China 22 395 1.6× 68 0.3× 208 1.2× 162 0.9× 199 1.1× 66 2.6k

Countries citing papers authored by Erkan Cüre

Since Specialization
Citations

This map shows the geographic impact of Erkan Cüre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkan Cüre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkan Cüre more than expected).

Fields of papers citing papers by Erkan Cüre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkan Cüre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkan Cüre. The network helps show where Erkan Cüre may publish in the future.

Co-authorship network of co-authors of Erkan Cüre

This figure shows the co-authorship network connecting the top 25 collaborators of Erkan Cüre. A scholar is included among the top collaborators of Erkan Cüre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkan Cüre. Erkan Cüre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cüre, Erkan & Medine Cumhur Cüre. (2025). Emerging risks of lipid-lowering therapy and low LDL levels: implications for eye, brain, and new-onset diabetes. Lipids in Health and Disease. 24(1). 185–185. 1 indexed citations
2.
Baykara, Rabia Aydoğan, et al.. (2024). Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome. Archives of Rheumatology. 39(3). 375–383. 2 indexed citations
3.
Baykara, Rabia Aydoğan, et al.. (2022). Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet’s disease. Clinical and Experimental Hypertension. 44(5). 480–486. 2 indexed citations
4.
Aydın, İbrahim, et al.. (2021). High dose zoledronic acid increases ischemia-reperfusion damage of the liver. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Küçük, Adem, et al.. (2021). Effects of the COVID-19 pandemic on psychology and disease activity in patients with ankylosing spondylitis and rheumatoid arthritis. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(4). 1631–1639. 13 indexed citations
6.
Baykara, Rabia Aydoğan, et al.. (2021). The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitis. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(4). 1865–1874. 7 indexed citations
7.
Cüre, Medine Cumhur & Erkan Cüre. (2021). Effects of the Na+/H+ Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease. Journal of the Renin-Angiotensin-Aldosterone System. 2021. 4754440–4754440. 6 indexed citations
8.
Cüre, Erkan, Adem Küçük, & Medine Cumhur Cüre. (2020). Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19). Rheumatology International. 40(7). 1177–1179. 25 indexed citations
9.
Cüre, Erkan & Medine Cumhur Cüre. (2020). COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets. Clinical and Applied Thrombosis/Hemostasis. 26. 2874332473–2874332473. 15 indexed citations
10.
Cüre, Erkan, Medine Cumhur Cüre, & Hülya Vatansev. (2020). Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension. Journal of the Renin-Angiotensin-Aldosterone System. 21(4). 2691695855–2691695855. 4 indexed citations
11.
Cüre, Erkan & Medine Cumhur Cüre. (2020). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(4). 349–350. 85 indexed citations
12.
Cüre, Erkan & Medine Cumhur Cüre. (2020). Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(4). 405–406. 67 indexed citations
13.
Küçük, Adem, Medine Cumhur Cüre, & Erkan Cüre. (2020). Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clinical Rheumatology. 39(7). 2103–2104. 56 indexed citations
14.
Cüre, Erkan, et al.. (2020). Angiotensin II, III, and IV may be important in the progression of COVID-19. Journal of the Renin-Angiotensin-Aldosterone System. 21(4). 2691695859–2691695859. 8 indexed citations
15.
Cüre, Erkan, Abdullah İçli, Ali Uğur Uslu, et al.. (2018). Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis. Clinical Rheumatology. 37(5). 1273–1280. 32 indexed citations
16.
Uslu, Ali Uğur, Erkan Cüre, Şevket Arslan, et al.. (2016). The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis. Zeitschrift für Rheumatologie. 76(1). 58–63. 31 indexed citations
17.
18.
Cüre, Medine Cumhur, Erkan Cüre, Aynur Kırbaş, Süleyman Yuce, & Ayşe Ertürk. (2014). Effects of Gilbert's Syndrome on Lipid Profile, Levels of Serum Uric Acid, Glucose and Insulin Resistance. SHILAP Revista de lepidopterología.
19.
Şahin, Figen Kır, Serap Baydur Şahin, Gülşah Balık, et al.. (2014). Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?. PubMed Central. 7(10). 3512–9. 15 indexed citations
20.
Cüre, Erkan, et al.. (2008). Behcet´s disease with gastric involvement: a case report. American Journal of Case Reports. 9. 4–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Medine Cumhur Cüre Breakdown of academic impact, for papers by Alessandra Barassi Breakdown of academic impact, for papers by Caterina Maria Gambino Breakdown of academic impact, for papers by İhsan Ateş Breakdown of academic impact, for papers by M. J. Brown Breakdown of academic impact, for papers by Concetta Scazzone Breakdown of academic impact, for papers by Ivan Tancevski Breakdown of academic impact, for papers by Sainan Zhu
Rankless by CCL
2026